Biotech Values

[mcbio]

Re: ARYX

Thanks for the response. It will be interesting to see what happens with the stock after the Tecarfarin results are released next week. I believe you've said before that the stock may be a buy if the results are negative and the stock tanks, given that the AF drug is a big opportunity on its own. I think it could be as well so next week should be interesting.